NVS Form 6-K: Report of foreign private issuer, 2012

Novartis AG Form 6-K: Report of foreign private issuer

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

2012-12-17: Form 6-K; Period of report 2012-12-14; Description SIGNIFOR(R) GAINS FDA APPROVAL; Document a12-29543_16k.htm.
2012-12-12: Form 6-K; Period of report 2012-12-11; Description 6-K; Document a12-28941_26k.htm.
2012-12-11: Form 6-K; Period of report 2012-12-10; Description 6-K; Document a12-28941_16k.htm.
2012-11-21: Form 6-K; Period of report 2012-11-20; Description 6-K; Document a12-27581_16k.htm.

Filed	Form	Period of report	Description	Document
2012-12-17	6-K	2012-12-14	SIGNIFOR(R) GAINS FDA APPROVAL	a12-29543_16k.htm
2012-12-12	6-K	2012-12-11	6-K	a12-28941_26k.htm
2012-12-11	6-K	2012-12-10	6-K	a12-28941_16k.htm
2012-11-21	6-K	2012-11-20	6-K	a12-27581_16k.htm
2012-11-16	6-K	2012-11-16	6-K	a12-27329_16k.htm
2012-11-09	6-K	2012-11-09	6-K	a12-26666_16k.htm
2012-11-09	6-K	2012-11-09	6-K	a12-26624_16k.htm
2012-11-08	6-K	2012-11-08	6-K	a12-26506_26k.htm
2012-11-08	6-K	2012-11-07	6-K	a12-26506_16k.htm
2012-11-07	6-K	2012-11-07	NOVARTIS PHASE III STUDY SHOWS RLX030 IMPROVED SYMPTOMS AND REDUCED DEATHS BY ON	a12-26349_16k.htm
2012-11-01	6-K	2012-10-31	6-K	a12-25796_16k.htm
2012-10-31	6-K	2012-10-31	NOVARTIS TO START CONSTRUCTION OF NEW BIOTECHNOLOGY FACILITY IN SINGAPORE.	a12-25682_16k.htm
2012-10-26	6-K	2012-10-25	6-K	a12-25273_16k.htm
2012-10-25	6-K	2012-09-30	6-K	a121025-6k.htm
2012-10-12	6-K	2012-10-12	6-K	a12-23659_16k.htm
2012-10-01	6-K	2012-10-01	6-K	a12-22516_16k.htm
2012-09-27	6-K	2012-09-27	6-K	a12-22174_16k.htm
2012-09-25	6-K	2012-09-25	6-K	a12-22023_16k.htm
2012-09-21	6-K	2012-09-21	6-K	a12-21772_26k.htm
2012-09-21	6-K	2012-09-21	6-K	a12-21772_16k.htm
2012-09-18	6-K	2012-09-18	6-K	a12-21343_16k.htm
2012-09-05	6-K	2012-09-05	6-K	a12-20217_16k.htm
2012-09-04	6-K	2012-09-03	6-K	a12-19789_16k.htm
2012-08-30	6-K	2012-08-30	6-K	a12-19472_16k.htm
2012-08-28	6-K	2012-08-28	6-K	a12-19102_16k.htm
2012-08-16	6-K	2012-08-15	6-K	a12-18409_16k.htm
2012-08-06	6-K	2012-08-06	6-K	a12-17727_16k.htm
2012-07-30	6-K	2012-07-30	6-K	a12-17239_16k.htm
2012-07-23	6-K	2012-07-20	6-K	a12-16779_16k.htm
2012-07-19	6-K	2012-06-30	6-K	a120719-6k.htm
2012-06-22	6-K	2012-06-22	6-K	a12-15147_26k.htm
2012-06-22	6-K	2012-06-22	6-K	a12-15147_16k.htm
2012-06-11	6-K	2012-06-11	6-K	a12-14463_16k.htm
2012-06-07	6-K	2012-06-06	6-K	a12-14225_16k.htm
2012-06-04	6-K	2012-05-31	6-K	a12-13543_16k.htm
2012-05-21	6-K	2012-05-17	6-K	a12-12373_16k.htm
2012-05-10	6-K	2012-05-10	6-K	a12-11794_16k.htm
2012-05-07	6-K	2012-05-07	6-K	a12-11419_16k.htm
2012-05-03	6-K	2012-05-03	6-K	a12-11177_16k.htm
2012-05-02	6-K	2012-05-01	6-K	a12-10975_16k.htm
2012-04-30	6-K	2012-04-27	6-K	a12-10620_16k.htm
2012-04-26	6-K	2012-04-25	6-K	a12-10386_16k.htm
2012-04-24	6-K	2012-03-31	6-K	a120424-6k.htm
2012-04-20	6-K	2012-04-20	6-K	a12-10059_36k.htm
2012-04-20	6-K	2012-04-20	6-K	a12-10059_56k.htm
2012-04-20	6-K	2012-04-20	6-K	a12-10059_46k.htm
2012-04-20	6-K	2012-04-19	6-K	a12-10059_16k.htm
2012-04-20	6-K	2012-04-19	6-K	a12-10059_26k.htm
2012-04-02	6-K	2012-04-02	6-K	a12-8571_16k.htm
2012-03-28	6-K	2012-03-28	6-K	a12-8240_16k.htm
2012-03-16	6-K	2012-03-16	6-K	a12-7335_16k.htm
2012-03-08	6-K	2012-03-07	6-K	a12-6738_16k.htm
2012-03-01	6-K	2012-02-29	6-K	a12-6163_26k.htm
2012-03-01	6-K	2012-02-29	6-K	a12-6163_16k.htm
2012-02-28	6-K	2012-02-27	6-K	a12-5918_16k.htm
2012-02-23	6-K	2012-02-23	6-K	a12-5716_16k.htm
2012-02-17	6-K	2012-02-17	6-K	a12-5346_16k.htm
2012-02-13	6-K	2012-02-13	6-K	a12-4833_16k.htm
2012-02-07	6-K	2012-02-07	6-K	a12-4416_16k.htm
2012-02-01	6-K	2012-02-01	6-K	a12-3952_16k.htm
2012-01-25	6-K	2011-12-31	6-K	a120125-6k.htm
2012-01-25	6-K	2012-01-25	6-K	a12-3437_16k.htm
2012-01-20	6-K	2012-01-20	6-K	a12-3180_16k.htm
2012-01-20	6-K	2012-01-20	6-K	a12-3177_16k.htm
2012-01-19	6-K	2012-01-19	6-K	a12-2990_16k.htm
2012-01-18	6-K	2012-01-18	6-K	a12-2882_16k.htm
2012-01-13	6-K	2012-01-13	6-K	a12-2698_16k.htm
2012-01-10	6-K	2012-01-08	6-K	a12-2342_16k.htm